Estimating Standard-Dose and High-Dose Fluzone Vaccine Efficacies for Influenza A Based on Hemagglutination Inhibition Titersjeanfrancoismaison2 days ago1 min readRated NaN out of 5 stars.https://pubmed.ncbi.nlm.nih.gov/39670611/
Discovery of novel and selective GPR17 antagonists as pharmacological tools for developing new therapeutic strategies in diabetes and obesityhttps://pubmed.ncbi.nlm.nih.gov/40460721/
Risk of COVID-19 reinfection and vaccine breakthrough infection, Madera County, California, 2021https://pubmed.ncbi.nlm.nih.gov/39191647/
Intrinsic immunogenicity is a major determinant of type-specific responses in SARS-CoV-2 infectionshttps://pubmed.ncbi.nlm.nih.gov/40425779/
Comentarios